SEC filing record
Primary Source · SEC.gov

Optima Healthcare & Biotech Fund Ltd

Fund Vehicle2026 vintage506(c), 3(c)
Latest signalSold increasedForm D/A · 2026-01-21Last filing 2026-01-21

Raised

$21M

Investors

20

Min Invest

$500,000

AltStreet Verified Issuer badge

Is this your company or fund? Claim this page free, or verify it and carry the Verified Issuer mark.

AltStreet Analysis

·

Generated from EDGAR primary sources

Optima Healthcare & Biotech Fund Ltd is a Bermuda-incorporated pooled investment fund that filed an amended Form D on 2026-01-21, reporting $21.0M raised from 20 investors under a $500K minimum investment threshold. The offering relies on Rule 506(c) combined with an Investment Company Act 3(c) exclusion, with Optima Asset Management LLC named as promoter alongside three listed directors; no first sale date is disclosed and no parent platform match was found.

This is a private equity pooled investment vehicle using the common 506(c)/3(c) exemption pairing seen in institutional alternative funds, with a $500K minimum investment placing it in the higher-accessibility tier relative to funds requiring $1M+ commitments. The offshore Bermuda domicile and small (20-investor) base are typical of niche sector-focused funds (here, healthcare & biotech) targeting accredited or qualified purchasers.

Data Flags

First Sale DateNo first sale date is disclosed, and total amount sold ($21.0M) is well under the $100M threshold where this omission would be expected for large institutional amendments — this is a pre-open or undisclosed-start filing on a comparatively smaller raise.
State of IncorporationFund is incorporated in Bermuda, an offshore jurisdiction, while filing a U.S. Form D — indicating a cross-border fund structure.
ExemptionFiling claims both Rule 506(c) and a 3(c) Investment Company Act exclusion simultaneously; this is a common structural pairing for private funds rather than a securities-exemption anomaly.

EDGAR Filing Data

Form D — Primary Source

View on SEC.gov
CIK Number0001799805
Entity NameOptima Healthcare & Biotech Fund Ltd
ExemptionRule 506(c), Section 3(c), Section 3(c)(7)
What the exemption meansRule 506(c) of Regulation D: the issuer may advertise the offering publicly, but every purchaser must be a verified accredited investor. Section 3(c) of the Investment Company Act of 1940: the issuer is a pooled investment vehicle relying on an exclusion from registration as an investment company. Section 3(c)(7) of the Investment Company Act: the fund is excluded from investment-company registration because every investor is a qualified purchaser, generally an individual with at least $5 million in investments or an institution with at least $25 million.
Entity TypeOther
Jurisdiction of OrganizationBermuda
Issuer Address4th Floor North, 41 Cedar Avenue, Hamilton, Bermuda HM12
Phone(441) 292-8900
Industry / Fund TypePooled Investment Fund · Hedge Fund
Investment Company ActExcluded under Section 3(c)(7) (qualified purchasers only)
Securities TypeEquity, Pooled Investment Fund
First Sale Date—
Filing DateJanuary 21, 2026
Accession Number0001799805-26-000001
Total Offering AmountIndefinite
Total Amount Sold$20,968,266
Total Investors20
Non-Accredited InvestorsNone
Minimum Investment$500,000
Offering DurationIntended to last more than one year
Sales Commissions$0
Finders' Fees$0
Net Asset Value RangeDecline to Disclose
State (Issuer Address)D0
Amendment Count7 filings on record

Filings on Record

Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.

In the Terminal

Filing events

2

latest Jan 21, 2026

Critical / warning

0 / 0

0 watch · 2 info

Statements extracted

0

none on file

NAV prints

0

none on file

Offering chains

1

raising

Latest event Sold increase · Jan 21, 2026

SEC.gov
Open in the terminal Watch this issuerInvestor $149/mo unlocks the values; Pro $349/mo adds the universe.

Fund family Part of the Optima Healthcare & Biotech Fund family: 2 vehicles across 0 generations · adviser of record Optima Asset Management LP · full family and the filing behind each link in the terminal

Investor

  • The full fund family and any related vehicles (parallel, feeder, successor, sibling series) with the filing that shows each link
  • 2 filing events with values and deltas, latest 2026-01-21, and alerts on the next one
  • 1 offering timeline: velocity, share raised, first-sale lag, stalled flags

Pro

  • This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
  • The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV

Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…

Related Persons (Form D)

Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.

Optima Asset Management LLC

Promoter · New York, NY

Geoffrey Lewis

Director · New York, NY

Thomas Davis

Director · Smith's Parish, D0

Neil Glass

Director · Devonshire, D0

Questions About Optima Healthcare & Biotech Fund Ltd

Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.

What is Optima Healthcare & Biotech Fund Ltd?

Optima Healthcare & Biotech Fund Ltd is a Bermuda entity that filed a Form D with the SEC on January 21, 2026 as a hedge fund. The filing claims Rule 506(c), Section 3(c), Section 3(c)(7) for an offering of equity and pooled investment fund interests.

Is Optima Healthcare & Biotech Fund Ltd legit?

AltStreet does not rate legitimacy; it reports the public record. Optima Healthcare & Biotech Fund Ltd filed a Form D with the SEC on January 21, 2026 claiming Rule 506(c), Section 3(c), Section 3(c)(7). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $20,968,266 sold to 20 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.

Is Optima Healthcare & Biotech Fund Ltd registered with or approved by the SEC?

No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that Optima Healthcare & Biotech Fund Ltd claimed Rule 506(c), Section 3(c), Section 3(c)(7) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.

How much has Optima Healthcare & Biotech Fund Ltd raised?

Optima Healthcare & Biotech Fund Ltd reported $20,968,266 sold from 20 investors in an offering of indefinite size as of the Form D filed January 21, 2026.

Who can invest in Optima Healthcare & Biotech Fund Ltd?

The offering relies on Rule 506(c), so the issuer may advertise it but may sell only to investors it has verified as accredited. Because the fund also relies on Section 3(c)(7), each investor must be a qualified purchaser, generally an individual with at least $5 million in investments. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $500,000.

What is the minimum investment in Optima Healthcare & Biotech Fund Ltd?

The Form D lists $500,000 as the minimum investment accepted from any outside investor as of January 21, 2026. Issuers can waive their own minimums, and the figure does not include fees.

Who is selling Optima Healthcare & Biotech Fund Ltd and how are they paid?

The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly. Sales commissions are reported as $0 and finders' fees as $0. Form D allows these to be estimates.

Who is behind Optima Healthcare & Biotech Fund Ltd?

The Form D lists 4 related persons: Optima Asset Management LLC, promoter (Manager); Geoffrey Manfred Lewis, director; Thomas Haskins Davis, director; Neil Haskins Glass, director. Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.

Where is Optima Healthcare & Biotech Fund Ltd located?

The issuer's address on its SEC filings is 4th Floor North, 41 Cedar Avenue, Hamilton, Bermuda HM12. Its phone number of record is 4412928900. It is organized under the laws of Bermuda.

How long is the Optima Healthcare & Biotech Fund Ltd offering open?

The issuer indicated that the offering is intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open; 6 amendments are on record for this CIK.

How large is Optima Healthcare & Biotech Fund Ltd?

The issuer declined to disclose its net asset value range on the Form D, which the form permits.

AltStreet Verified Issuer badge

Is this your company or fund?

Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.

Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.

Data Methodology

Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.